VLA-3: a novel polypeptide association within the VLA molecular complex: cell distribution and biochemical characterization
- PMID: 2430809
- DOI: 10.1002/eji.1830161106
VLA-3: a novel polypeptide association within the VLA molecular complex: cell distribution and biochemical characterization
Abstract
The family of human T cell activation-associated proteins, named VLA complex, is formed by the molecular association of cell surface glycoproteins of 210, 165, 130 and 80 kDa. In this report, we describe eight different monoclonal antibodies (HP mAb) specific for the 80-kDa polypeptide which preferentially associates with the 165-kDa member. Comparative immunoprecipitation and cell-binding studies demonstrated that the HP mAb recognize an epitope(s) on the 165/80 kDa subset different from those recognized by other anti-VLA mAb previously described. Furthermore, cellular and tissue distribution studies by flow cytometry and peroxidase staining showed that the HP reactivity pattern is different from other VLA specificities. The 165/80-kDa complex defined by HP mAb is present on human thymocytes, peripheral blood lymphocytes as well as on T, B and myelomonocytic cell lines. However, only the 80-kDa subunit was precipitated by HP mAb from activated T lymphocytes. These results suggest that the association between the 165- and 80-kDa subunits diminishes during the activation process, and that the epitopes recognized by the HP mAb are located on the 80-kDa protein. The novel polypeptide association of 165/80 kDa has been termed VLA-3.
Similar articles
-
A novel 90-kDa polypeptide (Tp90) possibly involved in an antigen-independent pathway of T cell activation.Eur J Immunol. 1987 Jun;17(6):835-41. doi: 10.1002/eji.1830170616. Eur J Immunol. 1987. PMID: 3036540
-
A novel 120-kDa antigen shared by immature human thymocytes and long-term-activated T cells.Eur J Immunol. 1994 Jan;24(1):1-7. doi: 10.1002/eji.1830240102. Eur J Immunol. 1994. PMID: 8020545
-
Use of the monoclonal antibody 12F1 to characterize the differentiation antigen VLA-2.J Immunol. 1987 Jan 1;138(1):226-33. J Immunol. 1987. PMID: 3023488
-
Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes.J Immunol. 1994 Feb 15;152(4):1662-73. J Immunol. 1994. PMID: 8120376
-
Very early (VEA) and very late (VLA) activation antigens have distinct functions in T lymphocyte activation.Immunol Rev. 1989 Jun;109:153-76. doi: 10.1111/j.1600-065x.1989.tb00024.x. Immunol Rev. 1989. PMID: 2670747 Review.
Cited by
-
Lymphocyte adhesion through very late antigen 4: evidence for a novel binding site in the alternatively spliced domain of vascular cell adhesion molecule 1 and an additional alpha 4 integrin counter-receptor on stimulated endothelium.J Exp Med. 1992 Jun 1;175(6):1433-42. doi: 10.1084/jem.175.6.1433. J Exp Med. 1992. PMID: 1375259 Free PMC article.
-
Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes.J Exp Med. 1997 Aug 18;186(4):589-600. doi: 10.1084/jem.186.4.589. J Exp Med. 1997. PMID: 9254657 Free PMC article.
-
Functional evidence that the HECA-452 antigen is involved in the adhesion of human neutrophils and lymphocytes to tumour necrosis factor-alpha-stimulated endothelial cells.Immunology. 1994 Mar;81(3):359-65. Immunology. 1994. PMID: 8206510 Free PMC article.
-
Vascular cell adhesion molecule 1 and alpha 4 and beta 1 integrins in lymphocyte aggregates in Sjögren's syndrome and rheumatoid arthritis.Ann Rheum Dis. 1993 Nov;52(11):806-11. doi: 10.1136/ard.52.11.806. Ann Rheum Dis. 1993. PMID: 7504438 Free PMC article.
-
Very late antigen (VLA) expression in various forms of epidermolysis bullosa simplex.Arch Dermatol Res. 1991;283(1):1-4. doi: 10.1007/BF01207240. Arch Dermatol Res. 1991. PMID: 2059055
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous